REVVITY, INC (RVTY) Shareholder Equity
- 2026-07-05: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $111.58M; Additional Paid in Capital, Common StockUSD $1.24B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $-256.55M.
- 2026-04-05: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $111.63M; Additional Paid in Capital, Common StockUSD $1.24B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $-253.55M.
- 2025-12-28: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $112.28M; Additional Paid in Capital, Common StockUSD $1.31B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $-221.06M.
- 2025-09-28: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $114.03M; Additional Paid in Capital, Common StockUSD $1.48B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $-178.66M.
REVVITY, INC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Treasury Stock, Value, Acquired, Cost Method USD | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-05 | $0.00 | $111.58M | $1.24B | $-256.55M | $-2.00K | $0.00 | $-256.55M | $6.13B | $7.23B | 3 month · $2.79M | (m) | (m) | (m) |
| 2026-04-05 | $0.00 | $111.63M | $1.24B | $-253.55M | $-2.00K | $0.00 | $-253.56M | $6.09B | $7.18B | 3 month · $2.89M | (m) | (m) | (m) |
| 2025-12-28 | $0.00 | $112.28M | $1.31B | $-221.06M | $-275.00K | $798.00K | $-222.13M | $6.05B | $7.25B | 12 month · $9.18M | (m) | (m) | (m) |
| 2025-09-28 | $0.00 | $114.03M | $1.48B | $-178.66M | $-348.00K | $798.00K | $-179.81M | $5.96B | $7.38B | 3 month · $2.35M | (m) | (m) | (m) |
| 2025-06-29 | $0.00 | $116.33M | $1.67B | $-156.34M | $-342.00K | $798.00K | $-157.48M | $5.93B | $7.56B | 3 month · $2.27M | (m) | (m) | (m) |
| 2025-03-30 | $0.00 | $119.41M | $1.95B | $-315.28M | $-369.00K | $798.00K | $-316.45M | $5.88B | $7.64B | 3 month · $2.09M | (m) | (m) | (m) |
| 2024-12-29 | $0.00 | $120.65M | $2.10B | $-394.94M | $-369.00K | $798.00K | $-396.11M | $5.85B | $7.67B | 12 month · $9.71M | (m) | (m) | (m) |
| 2024-09-29 | $0.00 | $122.09M | $2.27B | $-231.55M | $431.00K | $798.00K | $-231.91M | $5.76B | $7.92B | 3 month · $2.65M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $123.37M | $2.42B | $-341.32M | $186.00K | $798.00K | $-341.93M | $5.67B | $7.87B | 3 month · $2.47M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $123.49M | $2.42B | $-324.61M | $49.00K | $798.00K | $-325.35M | $5.63B | $7.85B | 3 month · $2.56M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $123.43M | $2.42B | $-275.68M | $-216.00K | $798.00K | $-276.69M | $5.61B | $7.87B | 12 month · $10.50M | 12 month · $90.81M | (m) | (m) |
| 2023-10-01 | $0.00 | $123.35M | $2.41B | $-378.69M | $252.00K | $798.00K | $-379.24M | $5.54B | $7.69B | 3 month · $2.51M | (m) | (m) | (m) |
| 2023-07-02 | $0.00 | $124.35M | $2.51B | $-304.44M | $262.00K | $798.00K | $-304.97M | $5.54B | $7.87B | 3 month · $2.89M | (m) | (m) | (m) |
| 2023-04-02 | $0.00 | $125.98M | $2.70B | $-303.84M | $259.00K | $798.00K | $-304.38M | $5.51B | $8.03B | 3 month · $3.03M | (m) | (m) | (m) |
| 2023-01-01 | $0.00 | $126.30M | $2.75B | $-446.66M | $-35.00K | $798.00K | $-447.50M | $4.95B | $7.38B | 12 month · $10.38M | (m) | (m) | (m) |
| 2022-10-02 | $0.00 | $126.22M | $2.75B | $-648.90M | $-35.00K | $842.00K | $-649.78M | $4.83B | $7.07B | 3 month · $1.94M | (m) | (m) | (m) |
| 2022-07-03 | $0.00 | $126.22M | $2.74B | $-458.16M | $-83.00K | $842.00K | $-459.08M | $4.76B | $7.17B | 3 month · $3.76M | (m) | (m) | (m) |
| 2022-04-03 | $0.00 | $126.14M | $2.72B | $-245.82M | $-56.00K | $842.00K | $-246.72M | $4.59B | $7.19B | 3 month · $2.79M | (m) | (m) | (m) |
| 2022-01-02 | $0.00 | $126.24M | $2.76B | $-161.81M | $-40.00K | $842.00K | $-162.69M | $4.42B | $7.14B | 12 month · $6.25M | (m) | (m) | (m) |
| 2021-10-03 | $0.00 | $126.20M | $2.74B | $-145.28M | $-173.00K | $747.00K | $-146.20M | $4.24B | $6.96B | 3 month · $1.48M | (m) | (m) | (m) |
| 2021-07-04 | $0.00 | $112.03M | $103.39M | $-91.52M | $-172.00K | $747.00K | $-92.44M | $4.12B | $4.24B | 3 month · $1.96M | (m) | (m) | (m) |
| 2021-04-04 | $0.00 | $112.07M | $115.69M | $-103.24M | $-183.00K | $747.00K | $-104.17M | $3.88B | $4.00B | 3 month · $899.00K | (m) | (m) | (m) |
| 2021-01-03 | $0.00 | $112.09M | $148.10M | $-30.94M | $-277.00K | $747.00K | $-31.96M | $3.51B | $3.74B | 12 month · $3.66M | (m) | (m) | (m) |
| 2020-10-04 | $0.00 | $111.88M | $128.82M | $-144.60M | $-219.00K | $-1.05M | $-143.77M | $3.13B | $3.23B | 3 month · $947.00K | (m) | (m) | (m) |
| 2020-07-05 | $0.00 | $111.50M | $106.74M | $-217.46M | $-262.00K | $-1.05M | $-216.67M | $2.97B | $2.97B | 3 month · $1.63M | (m) | (m) | (m) |
| 2020-04-05 | $0.00 | $111.31M | $90.24M | $-279.03M | $-349.00K | $-1.05M | $-278.33M | $2.84B | $2.76B | 3 month · $997.00K | (m) | (m) | (m) |
| 2019-12-29 | $0.00 | $111.14M | $90.36M | $-200.44M | $-261.00K | $-1.05M | $-199.65M | $2.81B | $2.81B | 12 month · $6.63M | (m) | (m) | (m) |
| 2019-09-29 | $0.00 | $111.09M | $84.00M | $-243.41M | $-289.00K | $-245.00K | $-243.46M | $2.76B | $2.71B | 3 month · $3.09M | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $111.07M | $72.18M | $-180.71M | $-284.00K | $-245.00K | $-180.75M | $2.70B | $2.71B | 3 month · $1.30M | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $110.89M | $58.09M | $-173.39M | $-387.00K | $-245.00K | $-173.53M | $2.64B | $2.64B | 3 month · $1.37M | (m) | (m) | (m) |
| 2018-12-30 | $0.00 | $110.60M | $48.77M | $-176.46M | $-267.00K | $-245.00K | $-176.48M | $2.60B | $2.58B | 12 month · $5.38M | 12 month · $-6.49M | (m) | (m) |
| 2018-09-30 | $0.00 | $111.09M | $89.97M | $-160.78M | $-190.00K | $-322.00K | $-160.65M | $2.53B | $2.57B | 3 month · $1.46M | (m) | (m) | (m) |
| 2018-07-01 | $0.00 | $110.72M | $73.74M | $-130.68M | $-213.00K | $-322.00K | $-130.57M | $2.46B | $2.52B | 3 month · $1.34M | (m) | (m) | (m) |
| 2018-04-01 | $0.00 | $110.62M | $65.66M | $-28.08M | $-217.00K | $-322.00K | $-27.98M | $2.41B | $2.56B | 3 month · $1.24M | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $110.36M | $58.83M | $-46.58M | $-258.00K | $-322.00K | $-46.52M | $2.38B | $2.50B | 12 month · $4.99M | (m) | (m) | (m) |
| 2017-10-01 | $0.00 | $110.21M | $50.04M | $-53.72M | $-256.00K | $-399.00K | $-53.58M | $2.43B | $2.54B | (m) | (m) | (m) | (m) |
| 2017-07-02 | $0.00 | $110.20M | $45.88M | $-63.52M | $-303.00K | $-399.00K | $-63.43M | $2.35B | $2.44B | (m) | (m) | (m) | (m) |
| 2017-04-02 | $0.00 | $109.86M | $31.15M | $-81.72M | $-314.00K | $-399.00K | $-81.63M | $2.15B | $2.21B | (m) | (m) | (m) | (m) |
| 2017-01-01 | $0.00 | $109.62M | $26.13M | $-100.92M | $-337.00K | $-399.00K | $-100.86M | $2.12B | $2.15B | 12 month · $4.63M | (m) | (m) | (m) |
| 2016-10-02 | $0.00 | $109.51M | $19.21M | $-55.71M | $-330.00K | $-1.26M | $-54.78M | $2.06B | $2.14B | (m) | (m) | (m) | (m) |
| 2016-07-03 | $0.00 | $109.39M | $13.13M | $-46.27M | $-339.00K | $-1.26M | $-45.35M | $2.01B | $2.09B | (m) | (m) | (m) | (m) |
| 2016-04-03 | $0.00 | $109.02M | $0.00 | $-15.28M | $-337.00K | $-1.26M | $-14.36M | $1.95B | $2.05B | (m) | (m) | (m) | (m) |
| 2016-01-03 | $0.00 | $112.03M | $52.93M | $-46.85M | $-369.00K | $-1.26M | $-45.96M | $1.99B | $2.11B | 12 month · $4.30M | (m) | (m) | $0.00 |
| 2015-10-04 | $0.00 | $111.91M | $44.79M | $-34.72M | $-250.00K | $-1.57M | $-33.40M | $1.93B | $2.05B | (m) | (m) | (m) | (m) |
| 2015-06-28 | $0.00 | $113.36M | $110.24M | $11.91M | $-170.00K | $-1.57M | $13.31M | $1.88B | $2.12B | (m) | (m) | (m) | (m) |
| 2015-03-29 | $0.00 | $113.19M | $102.67M | $-365.00K | $-136.00K | $-1.57M | $1.07M | $1.84B | $2.06B | (m) | (m) | (m) | (m) |
| 2014-12-28 | $0.00 | $112.48M | $94.28M | $23.33M | $-107.00K | $-1.57M | $24.80M | $1.81B | $2.04B | 12 month · $4.88M | (m) | (m) | $0.00 |
| 2014-09-28 | $0.00 | $112.96M | $114.22M | $46.69M | $-163.00K | $-1.43M | $47.95M | $1.79B | $2.06B | (m) | (m) | (m) | (m) |
| 2014-06-29 | $0.00 | $112.88M | $108.96M | $79.62M | $-151.00K | $-1.43M | $80.90M | $1.75B | $2.06B | (m) | (m) | (m) | (m) |
| 2014-03-30 | $0.00 | $113.10M | $127.47M | $76.92M | $-153.00K | $-1.43M | $78.19M | $1.71B | $2.03B | (m) | (m) | (m) | (m) |
| 2013-12-29 | $0.00 | $112.63M | $119.91M | $76.28M | $-121.00K | $-1.43M | $77.59M | $1.68B | $1.99B | 12 month · $4.45M | (m) | (m) | $0.00 |
| 2013-09-29 | $0.00 | $112.38M | $112.61M | $69.23M | $-119.00K | $-2.09M | $69.20M | $1.63B | $1.92B | (m) | (m) | (m) | $-2.00M |
| 2013-06-30 | $0.00 | $112.00M | $102.34M | $52.82M | $-159.00K | $-2.09M | $52.46M | $1.59B | $1.86B | (m) | (m) | (m) | $-2.29M |
| 2013-03-31 | $0.00 | $111.86M | $96.18M | $54.02M | $-118.00K | $-2.09M | $53.40M | $1.57B | $1.83B | (m) | (m) | (m) | $-2.59M |
| 2012-12-30 | $0.00 | $115.04M | $209.61M | $67.53M | $-129.00K | $-2.09M | $66.59M | $1.55B | $1.94B | 12 month · $5.02M | (m) | (m) | $-2.89M |
| 2012-09-30 | $0.00 | $114.59M | $196.57M | $60.03M | $-118.00K | $-2.17M | $58.89M | $1.57B | $1.94B | (m) | (m) | (m) | $-3.19M |
| 2012-07-01 | $0.00 | $114.06M | $182.32M | $39.59M | $-137.00K | $-2.17M | $38.13M | $1.55B | $1.89B | (m) | (m) | (m) | $-3.49M |
| 2012-04-01 | $0.00 | $113.83M | $175.42M | $69.93M | $-124.00K | $-2.17M | $68.19M | $1.53B | $1.88B | (m) | (m) | (m) | $-3.79M |
| 2012-01-01 | $0.00 | $113.16M | $164.29M | $56.16M | $-159.00K | $-2.17M | $54.09M | $1.51B | $1.84B | 12 month · $4.54M | (m) | (m) | $-4.09M |
| 2011-10-02 | $0.00 | $113.08M | $160.00M | $75.89M | $-157.00K | $102.57M | $-31.23M | $1.70B | $1.95B | (m) | (m) | (m) | $4.10M |
| 2011-07-03 | (m) | $113.08M | $157.11M | $117.73M | $-82.00K | $102.57M | $10.39M | $1.68B | $1.96B | (m) | (m) | 6 month · $107.80M | $-4.69M |
| 2011-04-03 | (m) | $112.71M | $146.09M | (m) | (m) | (m) | $-6.08M | $1.66B | $1.91B | (m) | (m) | (m) | (m) |
| 2011-01-02 | $0.00 | $115.72M | $224.01M | $54.35M | $-100.00K | $-2.06M | $51.03M | $1.53B | $1.93B | 12 month · $6.50M | (m) | (m) | $-5.28M |
| 2010-10-03 | (m) | $118.03M | $274.72M | (m) | (m) | (m) | $-44.92M | $1.36B | $1.71B | (m) | (m) | (m) | (m) |
| 2010-07-04 | (m) | $117.91M | $269.86M | (m) | (m) | (m) | $-98.15M | $1.35B | $1.64B | (m) | (m) | (m) | (m) |
| 2010-01-03 | (m) | $117.02M | $250.60M | $88.04M | $-164.00K | $-3.08M | $84.47M | $1.29B | $1.63B | 12 month · $8.58M | (m) | (m) | $-6.48M |
| 2008-12-28 | (m) | (m) | (m) | $83.11M | $-368.00K | $-3.35M | $78.41M | (m) | $1.57B | 12 month · $10.56M | (m) | (m) | $-7.68M |
| 2008-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-8.40M |
| 2007-12-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.58B | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |